Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Dynamic traction force measurements of migrating immune cells in 3D matrices (2025) Böhringer D, Cóndor M, Bischof L, Czerwinski T, Gampl N, Ngo P, Bauer A, et al. Unpublished / Preprint A novel Slide-seq based image processing software to identify gene expression at the single cell level (2024) Götz T, Cong X, Rauber S, Angeli MR, Lang EW, Ramming A, Schmidkonz C Journal article Linking IL-10 signaling with lipid metabolic programs in macrophages: dysregulated ceramide homeostasis drives colitis (2024) Atreya I, Neurath M Journal article Multispectral optoacoustic tomography of benign parotid tumors in vivo: a prospective observational pilot study (2024) Kouka M, Waldner M, Guntinas-Lichius O Journal article Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study (2024) Suzuki K, Sameshima Y, Yokoyama J, Terai S, Yoneyama H, Atreya R, Neurath M, et al. Journal article Gastric neuroendocrine neoplasms (2024) Lamberti G, Panzuto F, Pavel ME, O’Toole D, Ambrosini V, Falconi M, Garcia-Carbonero R, et al. Journal article Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article Unveiling Metabolic Similarities of Entheses in Patients with Psoriasis and Psoriatic Arthritis Using Noninvasive In Vivo Molecular Imaging: Results From a Cross-sectional Exploratory Study (2024) Fagni F, Tascilar K, Noversa de Sousa R, Bayat S, Sollfrank L, Kleyer A, Sticherling M, et al. Journal article US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study (2024) Sugimoto K, Moriyasu F, Burgio MD, Vilgrain V, Jesper D, Strobel D, Blank V, et al. Journal article Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024) Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al. Journal article